Tocqueville Asset Management L.P. lowered its position in shares of Edwards Lifesciences Co. (NYSE:EW – Get Rating) by 1.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 89,852 shares of the medical research company’s stock after selling 1,045 shares during […]
Bank of Nova Scotia raised its position in shares of Edwards Lifesciences Co. (NYSE:EW – Get Rating) by 120.1% in the fourth quarter, HoldingsChannel reports. The firm owned 901,992 shares of the medical research company’s stock after acquiring an additional 492,193 shares during the period. Bank of Nova Scotia’s holdings in Edwards Lifesciences were worth […]
Middleton & Co. Inc. MA grew its stake in Edwards Lifesciences Co. (NYSE:EW – Get Rating) by 76.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,720 shares of the medical research company’s stock after purchasing an additional 2,485 shares during the […]
Aviva PLC boosted its holdings in Edwards Lifesciences Co. (NYSE:EW – Get Rating) by 18.5% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 349,496 shares of the medical research company’s stock after buying an additional 54,585 shares during the quarter. Aviva PLC owned […]
Delaney Dennis R trimmed its position in Edwards Lifesciences Co. (NYSE:EW – Get Rating) by 6.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,720 shares of the medical research company’s stock after selling 175 shares during the […]